Micro Cap Stocks Mostly Lower (VICL, TSRX, CEDC, GNOM, KTCC)

Pompano Beach, FL -- (SBWIRE) -- 01/30/2013 -- Csrnewsdaily.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following Tuesday’s Top Gainers:-

Vical Incorporated (NASDAQ:VICL) added 5.04% and is trading at $3.54. Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases.

Can VICL Continue To Move Higher? Find Out Here

Trius Therapeutics, Inc. (NASDAQ:TSRX) is lower 1.99% and is trading at $5.18. Trius Therapeutics, Inc. operates as a biopharmaceutical research company. It has a cooperative research and development agreement with Lawrence Livermore National Security LLC for the research and development of gram-negative biodefense pathogens; and a license agreement with Dong-A Pharmaceutical Co., Ltd. to develop and sell Torezolid Phosphate outside of Korea.

How Should Investors Trade TSRX Now? Find Out Here

Central European Distribution Corp (NASDAQ:CEDC) is lower 1.11% and is trading at $1.78. Central European Distribution Corporation (CEDC), operates primarily in the alcohol beverage industry. CEDC is a producer of vodka and is Central and Eastern Europe’s integrated spirit beverages business. During the year ended December 31, 2011, as measured by total volume, the Company produced and distributed approximately 33.2 million nine-liter cases . The Company’s business primarily involves the production and sale of its own spirit brands (principally vodka), and the importation on a basis of a range of spirits, wines and beers.

Can CEDC Extend Rally? Find Out Here

Complete Genomics, Inc. (NASDAQ:GNOM) is lower 0.64% and is trading at $3.11. Complete Genomics, Inc. operates as a United States-based life sciences company. The Company develops and commercializes a deoxyribo nucleic acid (DNA) sequencing platform using components, chemistry, and computation to produce a human genome. Its Complete Genomics Analysis Tools (CGA Tools) is an open source project to provide tools for downstream analysis of genomics data produced by Complete Genomics.

How Should Investors React To GNOM Now? Find Out Here

Key Tronic Corporation (NASDAQ:KTCC) fell 18.14% and is trading at $9.75. Key Tronic Corporation (Key Tronic), is engaged in manufacturing computer keyboards. The Company provides a mix of manufacturing services for outsourced Original Equipment Manufacturing (OEM) products. The Company provides the EMS services, which include product design, surface mount technologies (SMT) and pin through hole capability for printed circuit board assembly, tool making, precision plastic molding, liquid injection molding, assembly, automated tape winding, prototype design and product assembly.

Can KTCC Extend Rally? Find Out Here

About Csrnewsdaily.com
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.

Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.

Disclaimer
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.

Contact:
Csrnewsdaily.com
info@csrnewsdaily.com